{"lastClose": 1.5800000429153442, "len": 432, "date": "2023-01-03", "alpha_1": -0.6164145423262964, "beta_1": 2.5112732221001166, "drawup_1": 0.6999999674883763, "natr_1": 28.79429468326702, "sup_1": -0.0400843740190857, "res_1": 1.0337551908539415, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 31.683169777586727, "adx_1": 52.6553911254483, "drawdown_1": -0.8181818044638325, "stratHoldSharpe_1": -1.2789547863257147, "stratHoldAlpha_1": 249.97908298934905, "stratHoldDrawdown_1": -0.7363636240174494, "alpha_3mo": -0.9402378143501487, "beta_3mo": 2.107311590579139, "drawup_3mo": 0.23913041900822218, "natr_3mo": 28.79429468326702, "sup_3mo": -0.04641348173531389, "res_3mo": 0.11603374206274271, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 31.7073238101607, "adx_3mo": 21.53774046495414, "drawdown_3mo": -0.48867311106702815, "stratHoldSharpe_3mo": -3.0491213789315297, "stratHoldAlpha_3mo": 248.7945271966801, "stratHoldDrawdown_3mo": -0.4398057999603253, "Sector": "Health Care", "Market Cap": 3036068489, "Name": "Ginkgo Bioworks Holdings Inc. Class A", "IPO Year": 2021.0, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Country": "United States", "alpha%_1": 0.06365752154480374, "beta%_1": 0.9982681000400426, "drawup%_1": 0.7619488412830451, "natr%_1": 1.0, "drawdown%_1": 0.021519119702340356, "stratHoldSharpe%_1": 0.09824045804750536, "stratHoldAlpha%_1": 0.001855378443703814, "stratHoldDrawdown%_1": 0.023385265938305047, "alpha%_3mo": 0.06934529426361007, "beta%_3mo": 0.9817824647723431, "drawup%_3mo": 0.45639796082415957, "natr%_3mo": 1.0, "drawdown%_3mo": 0.0010499285731804919, "stratHoldSharpe%_3mo": 0.009289885398508465, "stratHoldAlpha%_3mo": 9.19871753021751e-06, "stratHoldDrawdown%_3mo": 0.001319544272173292}